Axsome Therapeutics Inc. (NASDAQ:AXSM) ranks among the best mid-cap stocks with huge upside potential. H.C. Wainwright reaffirmed its Buy rating and $180 price target for Axsome Therapeutics Inc.
The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made ...
GSC Game World continue improving the recent S.T.A.L.K.E.R.: Legends of the Zone Trilogy release, with version 1.3 out for ...
After two months in the oven, 1.3 brings all the stuff you expect: bug fixes, tweaks, curtailed crashes, but most importantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback